個案資料
了解個案內容與學習目標，選擇授課教師及使用課程。
Abgenix and the XenoMouse
內容大綱
Abgenix has a unique method for generating antibodies useful in treating a number of diseases, including cancer. In early 2000, the company's cancer has performed very well in animal testing and is moving to early stage human testing. Abgenix must decide whether to sell the product development program to a large pharmaceutical company or to enter into a joint venture to push the product ahead.